Comment

Comment by plaidfuji

> “…the focus of AI in drug discovery must shift from doing what can be done - such as modelling data that is readily available, but that is unlikely to move the needle - to doing what should be done, even if this requires, for example, substantial data generation…” It’s a worthy goal, but I think that many involved in this work might be thinking, even unconsciously, “You first”.

This is the problem with AI for all of science - not just drug discovery. Applied ML has spread like wildfire through academia over the past decade - this started well before the LLM hype. It’s the perfect honey trap: research is painstaking and slow, ML offered a shortcut, and best of all, it just needs data. Research produces lots and lots of data! Surely this will be a match made in heaven.

I’ve watched the same pattern play out at least four or five times now in various roles.

(1) Propose an ML-guided approach to material/chemistry discovery/optimization.

(2) Gather existing data (real, experimental data).

(3) Realize there’s less than about 50 true rows of data on the outputs of interest.

At this point, you either: (4a) revert to traditional methods but keep the veneer of using ML to save face, or (4b) pivot to computational/simulation work or a high-throughput system that’s very far removed from your original problem, but allows you to keep playing with ML toys

It’s really bad. I left the industry. I don’t know how long it will take for people doing real science to take back the reins (and the funding).

parent plaidfuji 2 months ago

Discussion

Live from the official Hacker News API

A modern reader for Hacker News · SvelteKit + Skeleton